Hypertension 2025 Scientific Sessions  /  Recent Advances in Hypertension: GLP-1 Agonists  /  Combination Therapies in Kidney Disease: Revolutionizing Cardiovascular-Kidney-Metabolic Health
Logo

American Heart Association

  66
  0

Final ID:

Combination Therapies in Kidney Disease: Revolutionizing Cardiovascular-Kidney-Metabolic Health

  • Rangaswami, Janani  ( Washington DC VA Medical Center , Falls Church , Virginia , United States )
    • Author Disclosures:
    Janani Rangaswami: DO have relevant financial relationships ; Consultant:Boehringer Ingelheim:Active (exists now) ; Consultant:Procyrion:Active (exists now) ; Advisor:Bayer:Active (exists now)
Meeting Info:

Hypertension 2025 Scientific Sessions

2025

Baltimore, Maryland

Session Info:

Recent Advances in Hypertension: GLP-1 Agonists

Friday, 09/05/2025 , 08:00AM - 09:00AM

Recent Advances Plenary

More abstracts on this topic:
Understanding the GLP-1 Receptor as a Drug Target- Physiology Chasing Pharmacology

Dalessio David

More abstracts from these authors:
Don't Forget about the Kidneys!

Rangaswami Janani, Cherney David

Facilitating the equitable implementation of kidney care

Cervantes Lilia, Rangaswami Janani

You have to be authorized to contact abstract author. Please, Login
Not Available